American National Registered Investment Advisor’s Thermo Fisher Scientific TMO Stock Holding History

American National Registered Investment Advisor’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$2.6M	Sell	4,409 -969	-18%	-$557K	0.93%	16
2021 Q4	$3.59M	Sell	5,378 -1	-0%	-$624	1.18%	10
2021 Q3	$3.07M	Sell	5,379 -16	-0.3%	-$8.78K	1.11%	12
2021 Q2	$2.72M	Sell	5,395 -37	-0.7%	-$17.5K	0.97%	15
2021 Q1	$2.48M	Sell	5,432 -509	-9%	-$243K	0.96%	14
2020 Q4	$2.77M	Hold	5,941	–	–	1.1%	13
2020 Q3	$2.62M	Hold	5,941	–	–	1.2%	11
2020 Q2	$2.15M	Hold	5,941	–	–	1.07%	16
2020 Q1	$1.69M	Sell	5,941 -140	-2%	-$44.1K	1.05%	17
2019 Q4	$1.98M	Sell	6,081 -25	-0.4%	-$7.58K	0.98%	19
2019 Q3	$1.78M	Hold	6,106	–	–	0.98%	22
2019 Q2	$1.79M	Hold	6,106	–	–	1.01%	23
2019 Q1	$1.67M	Sell	6,106 -25	-0.4%	-$6.22K	0.93%	26
2018 Q4	$1.37M	Hold	6,131	–	–	0.86%	28
2018 Q3	$1.5M	Hold	6,131	–	–	0.79%	31
2018 Q2	$1.27M	Sell	6,131 -185	-3%	-$39.3K	0.61%	42
2018 Q1	$1.3M	Sell	6,316 -250	-4%	-$52.5K	0.65%	40
2017 Q4	$1.25M	Sell	6,566 -25	-0.4%	-$4.79K	0.59%	45
2017 Q3	$1.25M	Sell	6,591 -2,225	-25%	-$403K	0.63%	44
2017 Q2	$1.54M	Hold	8,816	–	–	0.64%	46
2017 Q1	$1.35M	Hold	8,816	–	–	0.58%	48
2016 Q4	$1.24M	Hold	8,816	–	–	0.57%	53
2016 Q3	$1.4M	Hold	8,816	–	–	0.65%	45
2016 Q2	$1.3M	Hold	8,816	–	–	0.61%	49
2016 Q1	$1.25M	Hold	8,816	–	–	0.6%	47
2015 Q4	$1.25M	Hold	8,816	–	–	0.61%	44
2015 Q3	$1.08M	Hold	8,816	–	–	0.56%	51
2015 Q2	$1.14M	Hold	8,816	–	–	0.55%	52
2015 Q1	$1.18M	Sell	8,816 -384	-4%	-$49.5K	0.57%	51
2014 Q4	$1.15M	Sell	9,200 -66	-0.7%	-$8.03K	0.53%	58
2014 Q3	$1.13M	Sell	9,266 -34	-0.4%	-$4.13K	0.54%	57
2014 Q2	$1.1M	Hold	9,300	–	–	0.52%	60
2014 Q1	$1.12M	Hold	9,300	–	–	0.56%	53
2013 Q4	$1.04M	Sell	9,300 -35	-0.4%	-$3.48K	0.52%	57
2013 Q3	$860K	Sell	9,335 -515	-5%	-$46.6K	0.49%	66
2013 Q2	$834K	Buy	+9,850	New	+$820K	0.47%	68

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American National Registered Investment Advisor's TMO Position: Q1 2022 in Review

American National Registered Investment Advisor reduced its Thermo Fisher Scientific (TMO) stake by 18% in Q1 2022, selling an estimated $557K and leaving 4,409 shares worth $2.6M. The position accounts for 0.93% of the portfolio, ranked #16.

American National Registered Investment Advisor first reported a position in TMO in Q2 2013 and has held it in 36 quarters since. The position peaked at $3.59M in Q4 2021. 2,313 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

American National Registered Investment Advisor held 4,409 shares of Thermo Fisher Scientific worth $2.6M as of Q1 2022.
American National Registered Investment Advisor sold 969 Thermo Fisher Scientific shares in Q1 2022, an estimated $557K.
Thermo Fisher Scientific made up 0.93% of American National Registered Investment Advisor's portfolio in Q1 2022, its #16 holding.
American National Registered Investment Advisor first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 36 quarters since.
American National Registered Investment Advisor's Thermo Fisher Scientific position peaked at $3.59M in Q4 2021.
2,313 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on American National Registered Investment Advisor's 13F filing for Q1 2022, filed 13 May 2022.